About 6 results found for searched term "TOFA" (0.053 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1820 | Tofacitinib | JAK |
| CP-690550, Tasocitinib | ||
| Tofacitinib (formerly tasocitinib, CP-690550) is a novel Janus Kinase 3 (JAK-3) kinase inhibitor with an IC50 value estimated at 0.2 μM. | ||
| M3616 | Tofacitinib citrate | JAK |
| CP-690550 citrate | ||
| Tofacitinib (CP-690550) Citrate is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1. | ||
| M8819 | TOFA | Others |
| RMI14514; MDL14514 | ||
| TOFA is an allosteric inhibitor of acetyl-CoA carboxylase-α (ACCA). TOFA can inhibit the anorectic effect of subcutaneous tamoxifen (TMX) on food intake during refeeding experiments in rats. | ||
| M14324 | Tofacitinib metabolite-1 | Others |
| Tofacitinib metabolite-1 is a metabolite of Tofacitinib, a JAK inhibitor. Tofacitinib metabolite-1 can be used in the pharmacokinetics and metabolism studies of tofacitinib. | ||
| M22368 | Fantofarone | Others |
| Fantofarone | ||
| M27778 | (3S,4S)-Tofacitinib | JAK |
| (3S,4S)-Tofacitinib is the less active S-enantiomer of Tofacitinib. Tofacitinib inhibits JAK3 with IC50 of 1 nM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
